Mr DUTTON (Dickson—Minister for Health and Minister for Sport) (19:09): I thank all members who have contributed to this very important debate. In particular, I thank Dr Gillespie for his contribution. He has served his local community for a long time, exceedingly well in the area of health. He knows the space well and is a great contributor to this place. The measures contained in the Therapeutic Goods Amendment (2013 Measures No. 1) Bill 2013 will contribute to a decrease in regulation, to a reduction in potential health risks to the Australian public; will involve transparency of the regulatory scheme and provide greater clarity and certainty about the operation of aspects of the Therapeutic Goods Act 1989; will give new power for the minister to exclude from the regulatory scheme low-risk products that do not represent a health risk to members of the public; and, will provide a basis for ensuring that only those goods for which Therapeutic Goods Act regulation is appropriate continue to be regulated. Claims made about the ability of household items, bedding or jewellery to improve a person's wellbeing or mood may well become caught by the regulatory scheme established by the act when such goods may more appropriately be dealt with under regulatory screens. By allowing the minister by disallowable instrument to exclude these products from the operation of the act, the focus of the regulatory scheme will remain on goods that have a connection with the alleviation, prevention or indeed treatment of medical conditions or with public health benefits and could, if they were not regulated under the act, represent a health risk to members of the public. The proposed powerful secretary to remove goods included in the Australian Register Of Therapeutic Goods that are not in fact therapeutic goods will also ensure that only those products which justify regulation under the act continue to be covered by the act. Products removed from the therapeutic goods regulatory scheme will still be subject to other more appropriate regulatory schemes such as consumer protection provisions in the Commonwealth Competition and Consumer Act 2010. Measures included in the bill to enable decisions of the TGA to be published on the TGA website as an alternative to publication in the Commonwealth of AustraliaGazette will benefit both consumers and industry by providing better access to important information about the TGA's regulatory activities as well as improve transparency in the operation of the regulatory scheme established under the act. In summary, the amendments in the bill make minor changes to the regulatory scheme for therapeutic goods with benefits to industry and consumers. The government will be giving further consideration to how the therapeutic goods regulatory scheme can continue to meet the needs of all of those who have an interest in its efficient and effective operation. The Australian public, industry, healthcare professionals and consumers in a constantly changing environment, while ensuring the focus remains on the promotion and protection of the health of all Australians. Question agreed to. Bill read a second time.